EUDA Health Holdings Limited

EUDA Health Holdings Limited is a Singapore-based healthcare innovator focused on non-invasive and preventive healthcare, with a strategic emphasis on the longevity sector across Asia, particularly in Singapore, Malaysia, and China. The company's mission is to facilitate a transition from reactive medical treatment to proactive, longevity-focused care, empowering individuals to lead healthier and more vibrant lives. Its headquarters are located in Singapore.

EUDA Health's offerings include bioenergy cabin therapy packages, stem cell therapy services provided through third-party treatment centers, and a range of holistic wellness consumer products and services. The company also operates a property management business, which contributes significantly to its revenue. Its digital healthcare ecosystem leverages an artificial intelligence platform to assess patient medical histories, triage conditions, connect patients with clinicians, and predict optimal treatment outcomes. Key products include EUDA Helixé, a supplement designed to activate longevity genes, and the Bioenergy Capsule, a multi-therapy wellness cabin.

Recent notable developments for EUDA Health include regaining compliance with Nasdaq's minimum market value requirements and expanding its Helixé product line with the launch of a Regenixé iPSC-Derived Skin Stem Cell Secretome Mask. The company also highlighted Shenzhen Inno's approval under a Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development, indicating its commitment to advanced regenerative medicine. Alfred Lim serves as the CEO and Executive Director.